Related Experiment Video
Updated: Feb 14, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Karyopherins in cancer
Tolga Çağatay1, Yuh Min Chook1
1Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract:
Malfunction of nuclear-cytoplasmic transport contributes to many diseases including cancer. Defective nuclear transport leads to changes in both the physiological levels and temporal-spatial location of tumor suppressors, proto-oncogenes and other macromolecules that in turn affect the tumorigenesis process and drug sensitivity of cancer cells. In addition to their nuclear transport functions in interphase, Karyopherin nuclear transport receptors also have important roles in mitosis and chromosomal integrity. Therefore, alterations in the expressions or regular functions of Karyopherins may have substantial effects on the course and outcome of diseases.
Insights
Nuclear-cytoplasmic transport defects impact cancer development and drug response by altering key protein levels and locations. Karyopherin dysfunction further affects mitosis and chromosomal integrity, influencing disease outcomes.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Nuclear-cytoplasmic transport is crucial for maintaining cellular homeostasis.
- Malfunctions in this transport system are implicated in various diseases, notably cancer.
- Karyopherins (importins/exportins) are key regulators of nuclear transport, affecting protein localization and function.
Purpose of the Study:
- To elucidate the role of nuclear-cytoplasmic transport in disease pathogenesis.
- To investigate the specific contributions of Karyopherin dysfunction to cancer development and progression.
- To understand how transport defects influence tumor suppressor and proto-oncogene activity.
Main Methods:
- Analysis of gene expression and protein localization in cancer models.
- Functional assays assessing Karyopherin activity during interphase and mitosis.
- Studies on the impact of Karyopherin alterations on tumorigenesis and drug sensitivity.
Main Results:
- Defective nuclear transport alters the levels and localization of critical oncogenes and tumor suppressors.
- Karyopherin dysregulation impacts mitotic progression and chromosomal stability.
- These alterations correlate with tumorigenesis and affect cancer cell drug sensitivity.
Conclusions:
- Nuclear-cytoplasmic transport is a critical determinant in cancer.
- Karyopherin malfunction significantly contributes to cancer development and progression.
- Targeting nuclear transport pathways may offer novel therapeutic strategies for cancer treatment.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

